However, UnitedHealth Group and Amedisys allege the lawsuit essentially ignores the companies' proposed divestiture package. The company didn’t identify which locations would be sold ...

Amedisys has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a market cap of $3.03 billion, a PE ratio of 36.71, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73.

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...

GAINESVILLE, Ga. — Northeast Georgia Medical Center has expanded with the opening of the new Green Tower on its Gainesville ...

Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...

UnitedHealth Group and Amedisys denied those allegations in their response filing Friday. In 2022, the government unsuccessfully sued to block Optum’s $13 billion acquisition of Change ...

OPCH Option Care Health, Inc.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.